Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001866583 | SCV002117642 | uncertain significance | Familial hemophagocytic lymphohistiocytosis 5 | 2021-12-02 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with STXBP2-related conditions. This variant is present in population databases (rs765133484, gnomAD 0.007%). This sequence change replaces histidine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 346 of the STXBP2 protein (p.His346Leu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |